Last 1,334 INR
Change Today 0.00 / 0.00%
Volume 0.0
WYH On Other Exchanges
Symbol
Exchange
Natl India
As of 6:06 AM 12/9/14 All times are local (Market data is delayed by at least 15 minutes).

wyeth ltd (WYH) Snapshot

Open
1,372
Previous Close
1,334
Day High
1,396
Day Low
1,328
52 Week High
12/8/14 - 1,410
52 Week Low
01/28/14 - 685.00
Market Cap
30.3B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
22.7M
EX-Date
12/5/13
P/E TM
--
Dividend
145.00
Dividend Yield
10.87%
Current Stock Chart for WYETH LTD (WYH)

Related News

No related news articles were found.

wyeth ltd (WYH) Related Businessweek News

No Related Businessweek News Found

wyeth ltd (WYH) Details

Wyeth Limited engages in manufacturing, marketing, and trading pharmaceutical and consumer healthcare products primarily in India. It operates in Pharmaceuticals and Others segments. The company offers antibiotics, steroids, vaccines, vitamins and hematinics, pre-filled syringes and vials, and other prescription medicines, as well as women’s health care products, such as hormone replacement therapy, oral contraceptives, and other gynecologicals. It also provides products in the therapeutic areas of cardiovascular diseases, central nervous system, transplantation/immunology, gastrointestinal, ophthalmology, and antiparasitic. In addition, the company offers OTC pharmaceuticals, cosmetics, and other allied consumer products. It also exports its products to other countries. The company was formerly known as Wyeth Lederle Limited and changed its name to Wyeth Limited in April 2003. The company was incorporated in 1947 and is based in Mumbai, India. Wyeth Limited is a subsidiary of Wyeth LLC. As of December 1, 2014, Wyeth Limited operates as a subsidiary of Pfizer Limited.

472 Employees
Last Reported Date: 10/16/14
Founded in 1947

wyeth ltd (WYH) Top Compensated Officers

Managing Director, Additional Non-Executive D...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

wyeth ltd (WYH) Key Developments

Wyeth Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

Wyeth Limited reported unaudited standalone earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales\income from operations of INR 2,063.9 million against INR 1,687.6 million a year ago. Profit from operations before other income and finance costs was INR 463.6 million against INR 182.9 million a year ago. Profit from operating activities before tax was INR 512.8 million against INR 281.8 million a year ago. Net profit from ordinary activities after tax was INR 335.6 million or INR 14.77 per basic and diluted share against INR 183.8 million or INR 8.09 per basic and diluted share a year ago. For the half year, the company reported net sales and income from operations of INR 3,975.7 million against INR 3,330.6 million a year ago. Profit from operations before other income and finance costs was INR 834 million against INR 430.6 million a year ago. Profit from operating activities before tax was INR 944.9 million against INR 620.5 million a year ago. Net profit from ordinary activities after tax was INR 620.2 million or INR 27.30 per basic and diluted share against INR 405.6 million or INR 17.85 per basic and diluted share a year ago.

Wyeth Limited to Report Q2, 2015 Results on Nov 06, 2014

Wyeth Limited announced that they will report Q2, 2015 results on Nov 06, 2014

Wyeth Limited, Board Meeting, Nov 06, 2014

Wyeth Limited, Board Meeting, Nov 06, 2014. Agenda: To consider and take on record the unaudited financial results (provisional) for the second quarter and six months ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WYH:IN 1,333.85 INR 0.00

WYH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amway Malaysia Hldgs Bhd 10.50 MYR 0.00
Array BioPharma Inc $4.75 USD +0.11
GlaxoSmithKline SAE £12.37 EGP 0.00
Progenics Pharmaceuticals Inc $7.24 USD +0.25
Spectrum Pharmaceuticals Inc $6.97 USD +0.07
View Industry Companies
 

Industry Analysis

WYH

Industry Average

Valuation WYH Industry Range
Price/Earnings 27.1x
Price/Sales 4.0x
Price/Book 8.9x
Price/Cash Flow 26.4x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WYETH LTD, please visit www.wyethindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.